Stem cell transplant for first relapse from the multiple myeloma research foundation.
Treatment regimens for multiple myeloma are evolving because of new advances in both pharmacotherapy and transplantation strategies. The Multiple Myeloma Research Foundation (MMRF) has gathered the top thought leaders in myeloma research to prepare an engaging interactive series of case studies in multiple myeloma, which are available online at www.multiplemyeloma.org and will be published on a regular basis in ONCOLOGY. For more information about the interactive series, see the MMRF ad on page 1881.
Anderson
Kenneth C
KC
St. Vincent's Comprehensive Cancer Center, New York, New York, USA.
Vesole
David H
DH
D000970:Antineoplastic Agents / Q000627:therapeutic use; D005582:Foundations; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D016879:Salvage Therapy; D033581:Stem Cell Transplantation
D000970:Antineoplastic Agents